Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Drug Resistance

  Free Subscription


03.10.2017

22 Antimicrob Agents Chemother
1 Crit Care Med
2 Infect Control Hosp Epidemiol
13 J Antimicrob Chemother
4 J Infect Dis
3 J Med Microbiol
1 N Engl J Med
2 PLoS Biol
1 PLoS Comput Biol
23 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. CHEN D, Cunningham SA, Cole NC, Kohner PC, et al
    Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  2. FARRELL DJ, Sader HS, Rhomberg PR, Scangarella-Oman NE, et al
    In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  3. PFALLER MA, Messer SA, Rhomberg PR, Castanheira M, et al
    Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  4. GROSSMAN NT, Casadevall A
    Physiological Differences in C. neoformans in vitro versus in vivo and Their Effects on Antifungal Susceptibility.
    Antimicrob Agents Chemother. 2016 Dec 28. pii: AAC.02108.
    PubMed     Text format     Abstract available

  5. PAPAGIANNITSIS CC, Tzouvelekis LS, Tzelepi E, Miriagou V, et al
    attI1-Located Small Open Reading Frames ORF-17 and ORF-11 in a Class 1 Integron Affect Expression of a Gene Cassette Possessing a Canonical Shine-Dalgarno Sequence.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  6. GERITS E, Defraine V, Vandamme K, De Cremer K, et al
    Repurposing Toremifene for Treatment of Oral Bacterial Infections.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  7. FREEMAN J, Pilling S, Vernon J, Wilcox MH, et al
    In Vitro Activities of MCB3681 and Eight Comparators against Clostridium difficile Isolates with Known Ribotypes and Diverse Geographical Spread.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  8. SONG KH, Kim M, Kim CJ, Cho JE, et al
    Impact of Vancomycin Minimum Inhibitory Concentration on Treatment Outcomes in Invasive Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2016 Dec 12. pii: AAC.01845.
    PubMed     Text format     Abstract available

  9. WENDEL AF, Kaase M, Autenrieth IB, Peter S, et al
    Protracted Regional Dissemination of GIM-1-Producing Serratia marcescens in Western Germany.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  10. ROBIN F, Beyrouthy R, Bonacorsi S, Aissa N, et al
    Inventory of Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  11. MARTIN-GUTIERREZ G, Rodriguez-Martinez JM, Pascual A, Rodriguez-Beltran J, et al
    Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  12. HALLOUM I, Viljoen A, Khanna V, Craig D, et al
    Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  13. JONES AK, Woods AL, Takeoka KT, Shen X, et al
    Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  14. ESTEBAN-CANTOS A, Aracil B, Bautista V, Ortega A, et al
    The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  15. LE VT, Le HN, Pinheiro MG, Hahn KJ, et al
    Effects of tedizolid phosphate on survival outcomes and suppression of production of staphylococcal toxins in a rabbit model of MRSA necrotizing pneumonia.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.02734.
    PubMed     Text format     Abstract available

  16. BABY N, Faust AC, Smith T, Sheperd LA, et al
    Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  17. HARTL R, Kerschner H, Lepuschitz S, Ruppitsch W, et al
    Detection of the mcr-1 Gene in a Multidrug-Resistant Escherichia coli Isolate from an Austrian Patient.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  18. LERKSUTHIRAT T, Sangcakul A, Lohnoo T, Yingyong W, et al
    Evolution of the Sterol Biosynthetic Pathway of Pythium insidiosum and Related Oomycetes Contributes to Antifungal Drug Resistance.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  19. MELETIADIS J, Curfs-Breuker I, Meis JF, Mouton JW, et al
    In vitro antifungal susceptibility testing of Candida isolates with the EUCAST methodology.
    Antimicrob Agents Chemother. 2017 Jan 23. pii: AAC.02372.
    PubMed     Text format     Abstract available

  20. MISHRA NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, et al
    Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis by a Novel Mechanism.
    Antimicrob Agents Chemother. 2017 Jan 23. pii: AAC.02435.
    PubMed     Text format     Abstract available

  21. SUN P, Bi Z, Nilsson M, Zheng B, et al
    Occurrence of blaKPC-2, blaCTX-M, and mcr-1 in Enterobacteriaceae from Well Water in Rural China.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  22. GROHS P, Taieb G, Morand P, Kaibi I, et al
    In Vitro Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


    Crit Care Med

  23. GRASSELLI G, Scaravilli V, Di Bella S, Biffi S, et al
    Nosocomial Infections During Extracorporeal Membrane Oxygenation: Incidence, Etiology, and Impact on Patients' Outcome.
    Crit Care Med. 2017;45:1726-1733.
    PubMed     Text format     Abstract available


    Infect Control Hosp Epidemiol

  24. KOHLER PP, Volling C, Green K, Uleryk EM, et al
    Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.
    Infect Control Hosp Epidemiol. 2017 Sep 27:1-10. doi: 10.1017/ice.2017.
    PubMed     Text format     Abstract available

  25. KWON JH, Reske KA, Hink T, Seiler SM, et al
    An Evaluation of the Prevalence of Vancomycin-Resistant Enterococci (VRE) and Methicillin-Resistant Staphylococcus aureus (MRSA) in Hospital Food.
    Infect Control Hosp Epidemiol. 2017 Sep 27:1-3. doi: 10.1017/ice.2017.
    PubMed     Text format    


    J Antimicrob Chemother

  26. ZELLWEGER RM, Carrique-Mas J, Limmathurotsakul D, Day NPJ, et al
    A current perspective on antimicrobial resistance in Southeast Asia.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. NIGRO SJ, Hall RM
    A large plasmid, pD46-4, carrying a complex resistance region in an extensively antibiotic-resistant ST25 Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format    

  28. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. ATKINSON CT, Kunde DA, Tristram SG
    Expression of acquired macrolide resistance genes in Haemophilus influenzae.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  31. DO NASCIMENTO V, Day MR, Doumith M, Hopkins KL, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of enteroaggregative Escherichia coli isolated from cases of diarrhoeal disease in England, 2015-16.
    J Antimicrob Chemother. 2017 Sep 11. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. HOMBACH M, Jetter M, Keller PM, Blochliger N, et al
    Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. PULCINI C
    Comment on: National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Sep 18. doi: 10.1093.
    PubMed     Text format    

  34. PRASKI ALZRIGAT L, Huseby DL, Brandis G, Hughes D, et al
    Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available

  35. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  36. MADELAIN V, Le MP, Champenois K, Charpentier C, et al
    Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
    J Antimicrob Chemother. 2017;72:1137-1146.
    PubMed     Text format     Abstract available

  37. CHAPMAN B, Slavin M, Marriott D, Halliday C, et al
    Changing epidemiology of candidaemia in Australia.
    J Antimicrob Chemother. 2017;72:1103-1108.
    PubMed     Text format     Abstract available

  38. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Infect Dis

  39. NIELSEN TB, Pantapalangkoor P, Luna BM, Bruhn KW, et al
    Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
    J Infect Dis. 2017;216:489-501.
    PubMed     Text format     Abstract available

  40. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    PubMed     Text format     Abstract available

  41. GUBAREVA LV, Sleeman K, Guo Z, Yang H, et al
    Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available

  42. CREANGA A, Hang NLK, Cuong VD, Nguyen HT, et al
    Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


    J Med Microbiol

  43. AZHAR A, Rasool S, Haque A, Shan S, et al
    Detection of high levels of resistance to linezolid and vancomycin in Staphylococcus aureus.
    J Med Microbiol. 2017 Aug 31. doi: 10.1099/jmm.0.000566.
    PubMed     Text format     Abstract available

  44. KONDRATYEVA K, Wollman A, Gerlitz G, Navon-Venezia S, et al
    Adhesion and invasion to epithelial cells and motility of extended-spectrum beta-lactamase-producing Escherichia coli reveal ST131 superiority: a comparative in vitro study of extraintestinal pathogenic E. coli lineages.
    J Med Microbiol. 2017;66:1350-1357.
    PubMed     Text format     Abstract available

  45. CHATTAWAY MA, Day M, Mtwale J, White E, et al
    Clonality, virulence and antimicrobial resistance of enteroaggregative Escherichia coli from Mirzapur, Bangladesh.
    J Med Microbiol. 2017 Sep 25. doi: 10.1099/jmm.0.000594.
    PubMed     Text format     Abstract available


    N Engl J Med

  46. XIE YL, Chakravorty S, Armstrong DT, Hall SL, et al
    Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med. 2017;377:1043-1054.
    PubMed     Text format     Abstract available


    PLoS Biol

  47. WAMBAUGH MA, Shakya VPS, Lewis AJ, Mulvey MA, et al
    High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.
    PLoS Biol. 2017;15:e2001644.
    PubMed     Text format     Abstract available

  48. YEN P, Papin JA
    History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment.
    PLoS Biol. 2017;15:e2001586.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  49. TEPEKULE B, Uecker H, Derungs I, Frenoy A, et al
    Modeling antibiotic treatment in hospitals: A systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies.
    PLoS Comput Biol. 2017;13:e1005745.
    PubMed     Text format     Abstract available


    PLoS One

  50. CHENG A, Chuang YC, Sun HY, Yang CJ, et al
    Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?
    PLoS One. 2017;12:e0180967.
    PubMed     Text format     Abstract available

  51. NARAYANASWAMY VP, Giatpaiboon S, Baker SM, Wiesmann WP, et al
    Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.
    PLoS One. 2017;12:e0179776.
    PubMed     Text format     Abstract available

  52. LAUDY AE, Rog P, Smolinska-Krol K, Cmiel M, et al
    Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods.
    PLoS One. 2017;12:e0180121.
    PubMed     Text format     Abstract available

  53. GOMEZ-GARZON C, Hernandez-Santana A, Dussan J
    A genome-scale metabolic reconstruction of Lysinibacillus sphaericus unveils unexploited biotechnological potentials.
    PLoS One. 2017;12:e0179666.
    PubMed     Text format     Abstract available

  54. AOKI Y, Kitazawa K, Kobayashi H, Senda M, et al
    Clinical features of children with nontyphoidal Salmonella bacteremia: A single institution survey in rural Japan.
    PLoS One. 2017;12:e0176990.
    PubMed     Text format     Abstract available

  55. TERVEER EM, Nijhuis RHT, Crobach MJT, Knetsch CW, et al
    Prevalence of colistin resistance gene (mcr-1) containing Enterobacteriaceae in feces of patients attending a tertiary care hospital and detection of a mcr-1 containing, colistin susceptible E. coli.
    PLoS One. 2017;12:e0178598.
    PubMed     Text format     Abstract available

  56. RANGEL M, Castro FFDS, Mota-Lima LD, Clissa PB, et al
    Polydim-I antimicrobial activity against MDR bacteria and its model membrane interaction.
    PLoS One. 2017;12:e0178785.
    PubMed     Text format     Abstract available

  57. BAG A, Chattopadhyay RR
    Synergistic antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-beta-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms.
    PLoS One. 2017;12:e0178712.
    PubMed     Text format     Abstract available

  58. BUNNELL BE, Escobar JF, Bair KL, Sutton MD, et al
    Zinc blocks SOS-induced antibiotic resistance via inhibition of RecA in Escherichia coli.
    PLoS One. 2017;12:e0178303.
    PubMed     Text format     Abstract available

  59. WONG CKM, Kung K, Au-Doung PLW, Ip M, et al
    Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care.
    PLoS One. 2017;12:e0177266.
    PubMed     Text format     Abstract available

  60. DOBROVOLNY HM, Beauchemin CAA
    Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.
    PLoS One. 2017;12:e0180582.
    PubMed     Text format     Abstract available

  61. NOWAK K, Fahr J, Weber N, Lubke-Becker A, et al
    Highly diverse and antimicrobial susceptible Escherichia coli display a naive bacterial population in fruit bats from the Republic of Congo.
    PLoS One. 2017;12:e0178146.
    PubMed     Text format     Abstract available

  62. TONG ML, Zhao Q, Liu LL, Zhu XZ, et al
    Whole genome sequence of the Treponema pallidum subsp. pallidum strain Amoy: An Asian isolate highly similar to SS14.
    PLoS One. 2017;12:e0182768.
    PubMed     Text format     Abstract available

  63. ILYUSHINA NA, Lugovtsev VY, Samsonova AP, Sheikh FG, et al
    Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses.
    PLoS One. 2017;12:e0181999.
    PubMed     Text format     Abstract available

  64. LIN B, Sun X, Su S, Lv C, et al
    HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.
    PLoS One. 2017;12:e0181997.
    PubMed     Text format     Abstract available

  65. ANDRE-GARNIER E, Besse B, Rodallec A, Ribeyrol O, et al
    An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.
    PLoS One. 2017;12:e0179562.
    PubMed     Text format     Abstract available

  66. GLADSTONE BP, Cona A, Shamsrizi P, Vilken T, et al
    Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use.
    PLoS One. 2017;12:e0181358.
    PubMed     Text format     Abstract available

  67. PALLAVALI RR, Degati VL, Lomada D, Reddy MC, et al
    Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
    PLoS One. 2017;12:e0179245.
    PubMed     Text format     Abstract available

  68. ZHU F, Yang Z, Zhang Y, Hu K, et al
    Transcriptome differences between enrofloxacin-resistant and enrofloxacin-susceptible strains of Aeromonas hydrophila.
    PLoS One. 2017;12:e0179549.
    PubMed     Text format     Abstract available

  69. IDH J, Andersson B, Lerm M, Raffetseder J, et al
    Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages.
    PLoS One. 2017;12:e0181221.
    PubMed     Text format     Abstract available

  70. WALKER SS, Labroli M, Painter RE, Wiltsie J, et al
    Antibacterial small molecules targeting the conserved TOPRIM domain of DNA gyrase.
    PLoS One. 2017;12:e0180965.
    PubMed     Text format     Abstract available

  71. NAGAYOSHI Y, Miyazaki T, Shimamura S, Nakayama H, et al
    Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    PLoS One. 2017;12:e0180990.
    PubMed     Text format     Abstract available

  72. DAHDOUH E, Gomez-Gil R, Pacho S, Mingorance J, et al
    Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital.
    PLoS One. 2017;12:e0176824.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: